EDITORIAL - MALIGNANCY-RELATED ASCITES AND ASCITIC FLUID HUMORAL TESTS OF MALIGNANCY

被引:30
作者
RUNYON, BA
机构
关键词
ASCITIC FLUID ANALYSIS; MALIGNANT ASCITES; MALIGNANCY-RELATED ASCITES; PERITONEAL CARCINOMATOSIS; CIRRHOTIC ASCITES; SERUM-ASCITES ALBUMIN GRADIENT;
D O I
10.1097/00004836-199403000-00002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A large number of ascitic fluid tests, e.g., fibronectin and cholesterol, have been proposed as helpful in detecting malignancy as the cause of ascites. Unfortunately, these ''humoral tests of malignancy'' are nonspecific. Although the ascitic fluid concentrations of these proteins or protein-bound substances tend to be quite high in patients with peritoneal carcinomatosis and low in the setting of cirrhotic ascites, the problem is that patients with tuberculous peritonitis, cardiac ascites, pancreatitis ascites, etc. usually have values in the malignancy range, ie., false-positive results. This can lead to an extensive search for a nonexistent tumor, with confusion and anxiety for patient and physician. The cytology is the single best test to order when peritoneal carcinomatosis is suspected; its sensitivity approaches 100%. However, peritoneal carcinomatosis is only one of several mechanisms by which tumors can cause ascites. No one test can be expected to detect tumors as the cause of these diverse mechanisms of ascites formation. The serum-ascites albumin gradient is a helpful test in classifying ascitic fluid specimens into portal-hypertension-related and non-portal-hypertension-related categories. An elevated serum cr-fetoprotein test can be useful in raising suspicion of hepatocellular carcinoma. Careful analysis of ascitic fluid, without measurement of ''humoral tests of malignancy,'' combined with information obtained from the history and physical examination, usually lead to an accurate diagnosis of the cause of ascites.
引用
收藏
页码:94 / 98
页数:5
相关论文
共 49 条
[11]  
Chetty R, 1990, Cytopathology, V1, P233, DOI 10.1111/j.1365-2303.1990.tb00352.x
[12]  
FRANCAVILLA A, 1984, HEPATOLOGY, V4, P1020
[13]  
GERBES A L, 1992, Journal of Hepatology, V16, pS28
[14]  
GERBES AL, 1991, CANCER, V68, P1808, DOI 10.1002/1097-0142(19911015)68:8<1808::AID-CNCR2820680827>3.0.CO
[15]  
2-6
[16]  
GERBES AL, 1988, HEPATOLOGY, V8, P1351
[17]  
HOEFS JC, 1983, J LAB CLIN MED, V102, P260
[18]  
JOHNSON WD, 1966, ACTA CYTOL, V10, P161
[19]   VALUE OF ASCITIC LIPIDS IN THE DIFFERENTIATION BETWEEN CIRRHOTIC AND MALIGNANT ASCITES [J].
JUNGST, D ;
GERBES, AL ;
MARTIN, R ;
PAUMGARTNER, G .
HEPATOLOGY, 1986, 6 (02) :239-243
[20]   PATHOPHYSIOLOGY OF ELEVATED ASCITES-FLUID CHOLESTEROL IN MALIGNANT ASCITES - INCREASED ASCITES TO SERUM RELATION OF PROTEINS AND LIPOPROTEINS IN PATIENTS WITH PERITONEAL CARCINOMATOSIS AS COMPARED TO PATIENTS WITH CIRRHOSIS OF THE LIVER [J].
JUNGST, D ;
XIE, YN ;
GERBES, AL .
JOURNAL OF HEPATOLOGY, 1992, 14 (2-3) :244-248